Lundbeck
HLUN-B.CO
#2346
Rank
NZ$10.56 B
Marketcap
$10.92
Share price
0.98%
Change (1 day)
20.87%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total debt

Total debt on the balance sheet as of June 2024 : NZ$0.96 B

According to Lundbeck 's latest financial reports the company's total debt is NZ$0.96 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Lundbeck - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$0.97 B-23.18%
2022-12-31NZ$1.26 B6.95%
2021-12-31NZ$1.18 B-34.76%
2020-12-31NZ$1.81 B-14.82%
2019-12-31NZ$2.12 B
2018-12-31N/A-100%
2017-12-31NZ$12.93 M-96.66%
2016-12-31NZ$0.38 B-52.04%
2015-12-31NZ$0.80 B16.11%
2014-12-31NZ$0.69 B42.94%
2013-12-31NZ$0.48 B17.93%
2012-12-31NZ$0.41 B-3.66%
2011-12-31NZ$0.42 B-4.39%
2010-12-31NZ$0.44 B-51.72%
2009-12-31NZ$0.92 B49.81%
2008-12-31NZ$0.61 B31.3%
2007-12-31NZ$0.47 B30.88%
2006-12-31NZ$0.36 B305.53%
2005-12-31NZ$88.93 M-15.04%
2004-12-31NZ$0.10 B